Predictive Value of Non-fasting Blood Lipid Levels for Cardiovascular Events in Community Population(PICC Study)

Lipid Clinical Trial

Official title:

Predictive Value of Non-fasting Blood Lipid Levels for Cardiovascular and Cerebrovascular Events in Community Population(PICC Study)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04212520
• Other study ID #: 2018150H(R2)
• Status: Recruiting
• Start date: January 1, 2020
• Est. completion date: December 31, 2050

Study information

• Verified date: December 2019
• Source: Guangdong Provincial People's Hospital
• Contact: Feng Ying-qing, PhD
• Phone: +862083827812
• Email: 651792209[@]qq.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Numerous studies have shown that non-fasting blood lipid levels are closely related to the occurrence of cardiovascular and cerebrovascular events, but it is still unclear in the Chinese population. The purpose of the study is to investigate the association between non-fasting blood lipid levels and adverse outcomes in Chinese community population.

Description:

Study population includes subjects who living in community, of any race or ethnicity, 18 or older years of age, and have provided written informed consent to provide biological sample at one or more study visits. Physical examination, questionnaire survey and biological sample collection will be conducted at baseline and the incidence of a composite of major adverse cardiovascular events will be investigated during follow-up.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 6500
• Est. completion date: December 31, 2050
• Est. primary completion date: December 31, 2023
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

•=18 years old;

• Signed informed consent;

• Life expectancy is greater than 1 year.

Exclusion Criteria:

• mental disorder;

• is not willing to participate in the clinical study;

• suffered with other disease to quite the trial;

• violated the protocol.

Related Conditions & MeSH terms

• Lipid

Intervention

Other:
• No intervention
No intervention

Locations

Country	Name	City	State
China	Guangdong Provincial People's Hospital	Guangzhou	Guangdong

Sponsors (1)

Lead Sponsor	Collaborator
Guangdong Provincial People's Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	All-cause mortality	All-cause mortality was confirmed through a combination of hospital medical records, telephone contacts with patients or family members, and death registration at the Center for Disease Control and Prevention.	Through study completion, an average of 1 years
Primary	Cardiovascular Mortality	Cardiovascular mortality was defined as death attributable to an ischemic cardiovascular cause (including fatal cardiovascular events and stroke).	Through study completion, an average of 1 years
Primary	Cardiovascular and cerebrovascular diseases	The number of and the incidence rate of cardiovascular and cerebrovascular diseases.	Through study completion, an average of 1 years